Adding catheter-directed thrombolysis to standard care cut risk for death and other bad ou ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA approves new COPD drug developed by firm in Raleigh. First new treatment in a decade A new COPD drug, developed by Verona ...

When you have chronic obstructive pulmonary disease (COPD), many factors go into what type of treatment youll receive, including the severity of your condition and your symptoms. But one variable is ...

Remember, COPD treatment is a long-term journey with many facets, and each case is different. For example, you might be great at keeping up with your medications and doctor appointments but not so ...

In patients with intermediate-high-risk pulmonary embolism, catheter-directed thrombolysis improved short-term clinical ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary ...

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...

Miami (March 4, 2026) – Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors ...

When living with chronic obstructive pulmonary disease (COPD), you can help prevent lung infections by quitting smoking and avoiding irritants such as secondhand smoke and strong scents. It’s ...

SGLT2 inhibitors and GLP-1 receptor agonists were associated with fewer exacerbations of COPD in adults with type 2 diabetes. There was little difference between SGLT2 inhibitors and GLP-1 receptor ...